Yturosuvastatin 5 mg (Rosuvastatin Calcium) Tablet
Rosuvastatin Calcium 5.2mg
Tablet · Prescription medication
Seongyi Bio Pharmaceutical Co., Ltd.
MFDS item code 202106979 · Approved 2021.10.18
Treatment of dyslipidemia; inhibition of the progression of atherosclerosis; prevention of cardiovascular disease
This medication is used in patients with primary hypercholesterolemia and mixed dyslipidemia who are not adequately controlled with diet and exercise, and it helps slow the progression of atherosclerosis due to hypercholesterolemia. It is also used as an adjunct to diet for patients with homozygous familial hypercholesterolemia. This medication is particularly utilized as an adjunct to diet in pediatric patients aged 10 to 17 years who exceed specific LDL cholesterol criteria. It is also beneficial for patients with primary dysbetalipoproteinemia, and in men over 50 years and women over 60 years with cardiovascular risk factors, it helps reduce the risk of stroke, myocardial infarction, and vascular revascularization. Overall, this medication is effectively used in the management of dyslipidemic disorders and reduction of cardiovascular disease risk.
1. Primary hypercholesterolemia (type IIa, including heterozygous familial hypercholesterolemia), mixed dyslipidemia (type IIb), primary dysbetalipoproteinemia (type III), and homozygous familial hypercholesterolemia Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine, and continue it throughout the treatment period. This medicine may be taken at any time of day, with or without food. The initial dose is 5 milligrams once daily. If a greater reduction in LDL cholesterol is needed, the dose may be adjusted to the maintenance dose. The maintenance dose is 10 milligrams once daily, which is adequate for most patients. The maintenance dose should be adjusted as appropriate at intervals of 4 weeks or more, according to LDL cholesterol levels, treatment goals, and patient response. The dose may be increased to a maximum of 20 milligrams daily. 3. Older adults: No dose adjustment is required. 4. Patients with renal impairment: No dose adjustment is required in patients with mild or moderate renal impairment. Do not administer to patients with severe renal impairment. Use particular caution when administering this medicine at a dose of 20mg to patients with moderate renal impairment. 5. Patients with hepatic impairment: No increase in systemic exposure to rosuvastatin was observed in patients with a Child-Pugh score of 7 or lower, but an increase was observed in patients with a Child-Pugh score of 8 or 9. Renal function testing should be considered in these patients. There is no experience with administration to patients with a Child-Pugh score greater than 9. Do not administer this medicine to patients with active liver disease. 6. Race: Because systemic exposure to this medicine is increased in Asian patients, the recommended initial dose is 5 milligrams. Administration of a 40-milligram dose is contraindicated. 7. Patients predisposed to myopathy: The recommended initial dose for patients predisposed to myopathy is 5 milligrams. Administration of a 40-milligram dose of this medicine is contraindicated in some of these patients.
Age 10 years ~ age 17 years: The usual dose range is 5 milligrams ~ 20 milligrams once daily. (There are no clinical data on doses greater than 20 milligrams in pediatric patients.) The dose should be individually adjusted according to the recommended treatment goal for each patient. The dose should be adjusted at intervals of 4 weeks or more. Under 10 years: Safety and efficacy have not been established.
This medication should not be used in certain patients. For example, individuals allergic to the components of this medication, those with severely impaired liver function, muscle disorders, those taking certain immunosuppressants, individuals with severe renal impairment, pregnant or breastfeeding women, and individuals with specific genetic diseases should not take this medication. Moreover, before taking this medication, it is essential to inform if there is a history of liver or kidney disease, thyroid dysfunction, or muscle disorders, as these patients should use this medication cautiously. This medication can cause muscle pain, weakness, and, rarely, severe muscle damage; therefore, if any unusual muscle symptoms occur, the physician should be informed immediately. It is important to receive regular liver function tests and muscle enzyme tests, especially when taking high doses. Caution is also necessary for those who consume alcohol heavily or have a history of liver disease. This medication can interact with other drugs, so it is crucial to inform healthcare providers of any other medications being taken. Particularly, muscle damage risk may increase when taken with certain antiviral agents, immunosuppressants, and fibrate medications. Women who are pregnant or may become pregnant must not use this medication and should implement appropriate contraception methods. Breastfeeding women should also avoid taking this medication. In the case of overdose, there is no specific antidote, so it is imperative to visit a medical facility immediately for treatment based on symptoms and to monitor liver function and muscle enzyme levels. This medication is not known to significantly affect driving or machine operation abilities; however, caution is warranted as dizziness may occur after intake. Lastly, if severe skin rashes or allergic reactions occur during treatment, it is essential to discontinue use immediately and consult a healthcare professional.
Hypersensitivity reactions including angioedema, diabetes, headache, dizziness, constipation, nausea, abdominal pain, pancreatitis, itching, rash, urticaria, myalgia, myopathy, rhabdomyolysis, weakness, polyneuropathy, amnesia, peripheral neuropathy, myasthenia gravis, cough, dyspnea, diarrhea, oculobulbar weakness, thrombocytopenia, jaundice, hepatitis, elevated transaminases, Stevens-Johnson syndrome, drug reaction with eosinophilia and systemic symptoms syndrome, drug rash with eosinophilia and systemic symptoms, lupus-like syndrome, muscle rupture, arthralgia, immune-mediated necrotizing myopathy, hematuria, edema, depression, sleep disorders, interstitial lung disease, sexual dysfunction, gynecomastia, both fatal and non-fatal liver failure, cognitive impairment, increased ALT, chest pain, muscle cramps, gout, erectile dysfunction, increased AST, numbness, paresthesia, chest discomfort, anorexia, abdominal distension, syncope, generalized pain, fatigue
Not everyone experiences these, and they can vary from person to person.
This medication must be stored in a tightly sealed container to prevent exposure to air and moisture. It is essential to maintain storage temperatures between 1 degree and 30 degrees Celsius at room temperature. This helps maintain the effectiveness of the medication and ensures safe use.
Pink round film-coated tablet
30 tablets/bottle, 100 tablets/bottle, 300 tablets/bottle, 30 tablets/box [15 tablets/PTP (Alu-Alu) x 2]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Rosuvastatin Calcium 5.2mg
Tablet · Prescription medication
Seongyi Bio Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 5.2mg
Tablet · Prescription medication
AstraZeneca Korea Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Chong Kun Dang Pharmaceutical Corp.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Dong Gu Bio Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 10.4mg
Tablet · Prescription medication
Boryung Pharmaceutical Co., Ltd.

Rosuvastatin Calcium 20.8mg
Tablet · Prescription medication
Jongkundang Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.